Cover Image

Molecular characterization of interdigitating dendritic cell sarcoma

Glen J. Weiss, Arlet Alarcon, Maqbool Halepota, Robert J. Penny, Daniel D. Von Hoff
  • Glen J. Weiss
    Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen, United States |
  • Arlet Alarcon
    Caris Life Sciences, United States
  • Maqbool Halepota
    Scottsdale Healthcare, United States
  • Robert J. Penny
    Caris Life Sciences, United States
  • Daniel D. Von Hoff
    Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen,


Interdigitating dendritic cell sarcoma is an extremely rare cancer that lacks a standard treatment approach. We report on a patient who was surgically resected and remains disease-free. The tumor was assessed for druggable targets using immunohistochemical staining to identify potential agents that could be used in the event of disease recurrence.


interdigitating dendritic cell sarcoma; SPARC; HSP90; treatment target

Full Text:

Submitted: 2010-05-14 19:19:11
Published: 2010-08-03 12:16:33
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM



Rare Tumors [ISSN 2036-3605, eISSN 2036-3613] is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.
© PAGEPress 2008-2016     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185